Tapewire

Nasdaq · USD

ACRS

Aclaris Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5041
SEC CIK
0001557746
Parsed reports
365

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 02, 2022 Filed Mar 3, 2022 23:08 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionCommon Stock 8,297 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-015809 · doc4.xml · nonDerivative · entry 3

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,706

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 23:04 UTC
Walker NealDirector · President and CEO
Exercise / conversionRestricted stock units · Derivative 18,254 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015794 · doc4.xml · derivative · entry 8

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,508

Underlying: Common Stock · 18,254 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F6 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F6 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 02, 2022 Filed Mar 3, 2022 23:04 UTC
Walker NealDirector · President and CEO
Exercise / conversionCommon Stock 18,254 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-015794 · doc4.xml · nonDerivative · entry 3

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,372,066

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 18:11 UTC
Monahan JosephChief Scientific Officer
Exercise / conversionRestricted stock units · Derivative 50,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015829 · doc4.xml · derivative · entry 8

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F5 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F5 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 18:11 UTC
Monahan JosephChief Scientific Officer
Exercise / conversionRestricted stock units · Derivative 13,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015829 · doc4.xml · derivative · entry 7

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,750

Underlying: Common Stock · 13,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F4 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F4 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 18:11 UTC
Monahan JosephChief Scientific Officer
GrantRestricted stock units · Derivative 43,700 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015829 · doc4.xml · derivative · entry 6

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,700

Underlying: Common Stock · 43,700 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F3 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2023, subject to the Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.

F3 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2023, subject to the Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 18:11 UTC
Monahan JosephChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 153,100 $0.00 Strike: $14.94 $0.00
Disclosure

SEC source: 0001209191-22-015829 · doc4.xml · derivative · entry 5

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,100

Underlying: Common Stock · 153,100 shares

Expires 2032-02-29

F2 · derivative.exercise_date: Exercisable with respect to 25% of the shares subject to the option vesting in four equal annual installments beginning on March 1, 2023, subject to Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 18:11 UTC
Monahan JosephChief Scientific Officer
Exercise / conversionCommon Stock 50,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-015829 · doc4.xml · nonDerivative · entry 2

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,051

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 18:11 UTC
Monahan JosephChief Scientific Officer
Exercise / conversionCommon Stock 13,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-015829 · doc4.xml · nonDerivative · entry 1

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,051

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:08 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionRestricted stock units · Derivative 8,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015809 · doc4.xml · derivative · entry 7

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,900

Underlying: Common Stock · 8,300 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F5 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F5 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:08 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionRestricted stock units · Derivative 25,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015809 · doc4.xml · derivative · entry 6

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,750

Underlying: Common Stock · 25,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F4 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F4 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:08 UTC
Ruffo FrankChief Financial Officer
GrantRestricted stock units · Derivative 44,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015809 · doc4.xml · derivative · entry 5

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,300

Underlying: Common Stock · 44,300 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F3 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2023, subject to the Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.

F3 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2023, subject to the Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:08 UTC
Ruffo FrankChief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 155,200 $0.00 Strike: $14.94 $0.00
Disclosure

SEC source: 0001209191-22-015809 · doc4.xml · derivative · entry 4

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,200

Underlying: Common Stock · 155,200 shares

Expires 2032-02-29

F2 · derivative.exercise_date: Exercisable with respect to 25% of the shares subject to the option vesting in four equal annual installments beginning on March 1, 2023, subject to Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:08 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionCommon Stock 8,300 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-015809 · doc4.xml · nonDerivative · entry 2

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 206,409

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:08 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionCommon Stock 25,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-015809 · doc4.xml · nonDerivative · entry 1

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:04 UTC
Walker NealDirector · President and CEO
Exercise / conversionRestricted stock units · Derivative 18,275 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015794 · doc4.xml · derivative · entry 7

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,825

Underlying: Common Stock · 18,275 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F5 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F5 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:04 UTC
Walker NealDirector · President and CEO
Exercise / conversionRestricted stock units · Derivative 96,150 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015794 · doc4.xml · derivative · entry 6

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,150

Underlying: Common Stock · 96,150 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F4 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

F4 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:04 UTC
Walker NealDirector · President and CEO
GrantRestricted stock units · Derivative 96,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015794 · doc4.xml · derivative · entry 5

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,000

Underlying: Common Stock · 96,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F3 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2023, subject to the Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.

F3 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2023, subject to the Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:04 UTC
Walker NealDirector · President and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 336,100 $0.00 Strike: $14.94 $0.00
Disclosure

SEC source: 0001209191-22-015794 · doc4.xml · derivative · entry 4

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 336,100

Underlying: Common Stock · 336,100 shares

Expires 2032-02-29

F2 · derivative.exercise_date: Exercisable with respect to 25% of the shares subject to the option vesting in four equal annual installments beginning on March 1, 2023, subject to Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:04 UTC
Walker NealDirector · President and CEO
Exercise / conversionCommon Stock 18,275 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-015794 · doc4.xml · nonDerivative · entry 2

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,353,812

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:04 UTC
Walker NealDirector · President and CEO
Exercise / conversionCommon Stock 96,150 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-015794 · doc4.xml · nonDerivative · entry 1

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,335,537

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 16:22 UTC
Monahan JosephChief Scientific Officer
SaleCommon Stock 383 $12.68 $4,857.13
Disclosure

SEC source: 0001209191-22-008860 · doc4.xml · nonDerivative · entry 1

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,301

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on February 1, 2022 pursuant to preexisting sell-to-cover elections.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 21:18 UTC
Ruffo FrankChief Financial Officer
SaleCommon Stock 1,388 $12.66 $17,568.47
Disclosure

SEC source: 0001209191-22-008849 · doc4.xml · nonDerivative · entry 1

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,359

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on February 1, 2022 pursuant to preexisting sell-to-cover elections.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 21:15 UTC
Walker NealDirector · President and CEO
SaleCommon Stock 3,595 $12.66 $45,513.42
Disclosure

SEC source: 0001209191-22-008837 · doc4.xml · nonDerivative · entry 1

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,239,387

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on February 1, 2022 pursuant to preexisting sell-to-cover elections.

F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $12.6601 to $12.6610, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 01, 2022 Filed Feb 1, 2022 16:50 UTC
Loerop JamesChief Business Officer
GrantRestricted Stock Units · Derivative 45,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-005935 · doc4.xml · derivative · entry 2

Loerop James · CIK 0001781549 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

F3 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

F3 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Read SEC document
February 01, 2022 Filed Feb 1, 2022 16:50 UTC
Loerop JamesChief Business Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 155,000 $0.00 Strike: $11.58 $0.00
Disclosure

SEC source: 0001209191-22-005935 · doc4.xml · derivative · entry 1

Loerop James · CIK 0001781549 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,000

Underlying: Common Stock · 155,000 shares

Expires 2032-01-31

F1 · derivative.exercise_date: Exercisable with respect to 25% of the shares subject to the option vesting in four equal annual installments beginning on February 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 16:49 UTC
Monahan JosephChief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 1,050 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-006836 · doc4.xml · derivative · entry 3

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,050 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F2 · derivative.exercise_date: The shares underlying these restricted stock units vested on February 1, 2022.

F2 · derivative.expiration_date: The shares underlying these restricted stock units vested on February 1, 2022.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 16:49 UTC
Monahan JosephChief Scientific Officer
Exercise / conversionCommon Stock 1,050 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-006836 · doc4.xml · nonDerivative · entry 1

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:46 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 3,875 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-006832 · doc4.xml · derivative · entry 2

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F2 · derivative.exercise_date: The shares underlying these restricted stock units vested on February 1, 2022.

F2 · derivative.expiration_date: The shares underlying these restricted stock units vested on February 1, 2022.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:46 UTC
Ruffo FrankChief Financial Officer
Exercise / conversionCommon Stock 3,875 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-006832 · doc4.xml · nonDerivative · entry 1

Ruffo Frank · CIK 0001654450 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,747

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:43 UTC
Walker NealDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 10,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-006826 · doc4.xml · derivative · entry 2

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,800 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F2 · derivative.exercise_date: The shares underlying these restricted stock units vested on February 1, 2022.

F2 · derivative.expiration_date: The shares underlying these restricted stock units vested on February 1, 2022.

Read SEC document
February 01, 2022 Filed Feb 3, 2022 21:43 UTC
Walker NealDirector · President and CEO
Exercise / conversionCommon Stock 10,800 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-006826 · doc4.xml · nonDerivative · entry 1

Walker Neal · CIK 0001604457 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,242,982

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:33 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 7,100 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-001712 · doc4.xml · derivative · entry 8

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,400 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: Represents the number of restricted stock units that were accelerated by mutual agreement between the Reporting Person and the Issuer. The balance of unvested restricted stock units, if any, were forfeited.

F6 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

F6 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:33 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionRestricted Stock Unit · Derivative 6,638 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-001712 · doc4.xml · derivative · entry 7

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,914 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: Represents the number of restricted stock units that were accelerated by mutual agreement between the Reporting Person and the Issuer. The balance of unvested restricted stock units, if any, were forfeited.

F5 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

F5 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:33 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 27,905 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-001712 · doc4.xml · derivative · entry 6

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 34,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: Represents the number of restricted stock units that were accelerated by mutual agreement between the Reporting Person and the Issuer. The balance of unvested restricted stock units, if any, were forfeited.

F4 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

F4 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:33 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 3,875 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-001712 · doc4.xml · derivative · entry 5

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

F2 · shares: Represents the number of restricted stock units that were accelerated by mutual agreement between the Reporting Person and the Issuer. The balance of unvested restricted stock units, if any, were forfeited.

F3 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2019, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

F3 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on February 1, 2019, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:33 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionCommon Stock 7,100 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-001712 · doc4.xml · nonDerivative · entry 4

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,214

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:33 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionCommon Stock 6,638 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-001712 · doc4.xml · nonDerivative · entry 3

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,114

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:33 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionCommon Stock 27,905 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-001712 · doc4.xml · nonDerivative · entry 2

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,476

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:33 UTC
Ali-Jackson KamilChief Legal Officer
Exercise / conversionCommon Stock 3,875 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-001712 · doc4.xml · nonDerivative · entry 1

Ali-Jackson Kamil · CIK 0001654337 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,571

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Read SEC document
November 23, 2021 Filed Dec 3, 2021 16:52 UTC GiftCommon Stock 5,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-067863 · doc4.xml · nonDerivative · entry 1

Powell Andrew Kenneth William · CIK 0001304113 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,209

Read SEC document
November 01, 2021 Filed Nov 3, 2021 20:17 UTC OtherCommon Stock 8,276 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-062697 · doc4.xml · nonDerivative · entry 4

Foresite Capital Management III, LLC · CIK 0001645157 · 10% owner

Foresite Capital Fund III, L.P. · CIK 0001645158 · 10% owner

Foresite Capital Management IV, LLC · CIK 0001704132 · 10% owner

Foresite Capital Fund IV, L.P. · CIK 0001704131 · 10% owner

Foresite Capital Management V, LLC · CIK 0001792206 · 10% owner

Foresite Capital Fund V, L.P. · CIK 0001792204 · 10% owner

Tananbaum James B. · CIK 0001581754 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 8,276

F5 · kind: Represents shares received by the James B. Tananbaum and Dana Shonfeld Tananbaum Family Trust pursuant to pro rata distributions by Fund III and FCM III, for no consideration, of shares of the Issuer's Common Stock to their respective partners or members, as applicable. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.

F6 · ownership.nature: These shares are held of record by a family trust for which Mr. Tananbaum is a trustee. Each of the Reporting Persons disclaims the existence of a "group" and, other than Mr. Tananbaum, disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 20:17 UTC OtherCommon Stock 1,954,904 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-062697 · doc4.xml · nonDerivative · entry 1

Foresite Capital Management III, LLC · CIK 0001645157 · 10% owner

Foresite Capital Fund III, L.P. · CIK 0001645158 · 10% owner

Foresite Capital Management IV, LLC · CIK 0001704132 · 10% owner

Foresite Capital Fund IV, L.P. · CIK 0001704131 · 10% owner

Foresite Capital Management V, LLC · CIK 0001792206 · 10% owner

Foresite Capital Fund V, L.P. · CIK 0001792204 · 10% owner

Tananbaum James B. · CIK 0001581754 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

F1 · kind: On November 1, 2021, Foresite Capital Fund III, L.P. ("Fund III") distributed, for no consideration, 1,954,904 shares of the Issuer's Common Stock (the "Fund III Shares") to its limited partners and to Foresite Capital Management III, LLC ("FCM III"), the general partner of Fund III, representing each such partner's pro rata interest in such Fund III Shares. On the same date, FCM III distributed, for no consideration, the Fund III Shares it received in the distribution by Fund III to its members, representing each such member's pro rata interest in such Fund III Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.nature: The shares are owned directly by Fund III. FCM III is the general partner of Fund III, may be deemed to have sole voting and dispositive power over these shares. James B. Tananbaum ("Mr. Tananbaum") is the sole managing member of FCM III and may be deemed to have sole voting and dispositive power over these shares. Each Reporting Person disclaims the existence of a "group." Each of FCM III and Mr. Tananbaum disclaims beneficial ownership of any of these shares except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that FCM III or Mr. Tananbaum is the beneficial owner of these shares for purposes of Section 16 or any other purpose.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 17:39 UTC
Monahan JosephChief Scientific Officer
Exercise / conversionRestricted Stock Units · Derivative 2,333 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-054530 · doc4.xml · derivative · entry 4

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,333 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F3 · derivative.exercise_date: The shares underlying these restricted stock units vested on September 1, 2021.

F3 · derivative.expiration_date: The shares underlying these restricted stock units vested on September 1, 2021.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 17:39 UTC
Monahan JosephChief Scientific Officer
Tax withholdingCommon Stock 1,041 $17.22 $17,926.02
Disclosure

SEC source: 0001209191-21-054530 · doc4.xml · nonDerivative · entry 2

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,634

F2 · kind: The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.

Read SEC document
September 01, 2021 Filed Sep 2, 2021 17:39 UTC
Monahan JosephChief Scientific Officer
Exercise / conversionCommon Stock 2,333 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-054530 · doc4.xml · nonDerivative · entry 1

Monahan Joseph · CIK 0001861790 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,675

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
July 13, 2021 Filed Jul 14, 2021 21:32 UTC
Gordon David N.Chief Medical Officer
SaleCommon Stock 2,631 $16.98 $44,674.64
Disclosure

SEC source: 0001209191-21-046683 · doc4.xml · nonDerivative · entry 1

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,447

F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on July 2, 2021 pursuant to preexisting sell-to-cover elections.

F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.9755 to $17.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
July 02, 2021 Filed Jul 7, 2021 22:03 UTC
Gordon David N.Chief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-045899 · doc4.xml · derivative · entry 2

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F2 · derivative.exercise_date: The shares underlying these restricted stock units vest over a period of four years, with 25% vesting on the first, second, third and fourth anniversaries of the date of grant, beginning on July 2, 2019 and subject to the reporting person's continuous service with the issuer as of the applicable vesting date.

F2 · derivative.expiration_date: The shares underlying these restricted stock units vest over a period of four years, with 25% vesting on the first, second, third and fourth anniversaries of the date of grant, beginning on July 2, 2019 and subject to the reporting person's continuous service with the issuer as of the applicable vesting date.

Read SEC document
July 02, 2021 Filed Jul 7, 2021 22:03 UTC
Gordon David N.Chief Medical Officer
Exercise / conversionCommon Stock 6,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-045899 · doc4.xml · nonDerivative · entry 1

Gordon David N. · CIK 0001751167 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,078

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

Read SEC document
June 03, 2021 Filed Jun 4, 2021 20:12 UTC GrantRestricted Stock Units · Derivative 3,356 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-038459 · doc4.xml · derivative · entry 2

SCHIFF ANDREW N · CIK 0001172252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,356

Underlying: Common Stock · 3,356 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.

F1 · derivative.exercise_date: This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy.

F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date.

F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.